| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/01/2008 | US7351803 CD16A binding proteins and use for the treatment of immune disorders |
| 04/01/2008 | US7351790 Peptide-based compounds |
| 04/01/2008 | US7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 04/01/2008 | US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 04/01/2008 | US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient |
| 04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
| 04/01/2008 | US7351693 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 04/01/2008 | US7351692 Method and composition for potentiating the antipyretic action of a nonopioid analgesic |
| 04/01/2008 | US7351555 Expression vector comprising nucleotide sequences coding cytokine receptor (Zcytor16) for use as antagonist tool of interleukin-10 related t-cell derived inducible factor in diagnosis, treatment and prevention of cell proliferative and inflammatory disorders |
| 04/01/2008 | CA2446574C Liquid pharmaceutical composition |
| 04/01/2008 | CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 04/01/2008 | CA2363990C Use of glycyrrhizin in the treatment of mastitis |
| 04/01/2008 | CA2299288C Non-steroidal antiinflammatory drug formulations for topical application to the skin |
| 03/27/2008 | WO2008036653A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | WO2008036579A1 Thiazole pyrazolopyrimidines as crf1 receptor antagonists |
| 03/27/2008 | WO2008036379A2 Serine hydrolase inhibitors |
| 03/27/2008 | WO2008035823A1 Cell death inhibitor |
| 03/27/2008 | WO2008035756A1 Anti-angiogenic composition comprising extract having anti-angiogenic activity and lecithin |
| 03/27/2008 | WO2008035583A1 Moisturizing agent, cell-activating agent, antioxidant agent, protease activity enhancing agent, anti-aging agent, skin-whitening agent, anti-inflammatory agent, and neutral fat accumulation-inhibiting agent |
| 03/27/2008 | WO2008035572A1 Moisturizing agent, anti-aging agent, skin-whitening agent, antiinflammatory agent, and antioxidant agent |
| 03/27/2008 | WO2008035566A1 Cell activator, collagen production promoter, collagenase activity inhibitor, melanin formation inhibitor, antioxidant agent, antiinflammatory agent, fat accumilation inhibitor, external preparation for skin, and food |
| 03/27/2008 | WO2008034860A1 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors |
| 03/27/2008 | WO2008012563A3 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 03/27/2008 | WO2008010934A3 Triazolyl phenyl benzenesulfonamides |
| 03/27/2008 | WO2008001110A3 Manganese, zinc and selenium compositions, preparations and uses |
| 03/27/2008 | WO2007147497A3 Use of a disintegrin-like and metalloproteinase with thrombospondin type 1 motif (adamts1) as a therapeutic or diagnostic target |
| 03/27/2008 | WO2007092939A3 Antigenic gm-csf peptides and antibodies to gm-csf |
| 03/27/2008 | WO2007057508A3 Treatment of pain with a combination of an alpha2 -adrenoceptor antagonist such as atipemezole or fipamezoiie and an opioid receptor agonist, such as tramadol |
| 03/27/2008 | US20080077372 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 03/27/2008 | US20080076813 Benzene, Pyridine, and Pyridazine Derivatives |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076783 Cycloalkyl Keto Piperidine Tachykinin Receptor Antagonists |
| 03/27/2008 | US20080076778 PARP (poly-ADP ribose polymerase); drug screening; computer networks |
| 03/27/2008 | US20080076775 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 03/27/2008 | US20080076772 Anti-Inflammatory Agents |
| 03/27/2008 | US20080076768 Pharmaceutical compounds |
| 03/27/2008 | US20080076758 1S,4S)-2-((2-(1H-indazol-4-yl)-4- morpholinothieno[3,2-d]pyrirnidin-6- yl)methyl)-5-methylsulfonyl-2,5- diaza-bicyclo[2.2.1]heptane; 2-(6-fluoropyridin-3-yl)-6-((4- methylsulfonylpiperazin-1-yl)methyl)-4- morpholinothieno[3,2-d]pyrimidine; treats cancer mediated by pik3 kinase; enzyme inhibitors |
| 03/27/2008 | US20080076755 4-(Adamantane-1-carbonylamino)-3-oxo-2-aza-bicyclo[2.2.2]octane; 5-(Adamantane-1-carbonylamino)-10-oxo-9-aza-bicyclo[3.3.2]decane for treating autoimmune diseases, vascular disorders, viral infection or replication, asthma, osteoporosis, tumor growth, rheumatoid arthritis, organ transplant rejection |
| 03/27/2008 | US20080076744 Method for treating inflammatory conditions with progesterone or progesterone analogs |
| 03/27/2008 | US20080076712 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/27/2008 | US20080076707 Topically administering cyclosporin A; lupus, multiple sclerosis, skin disorders, oral diseases, autoimmune diseases, respiratory system disorders; antiulcer agents, anticarcinogenic agents, antiarthritic agents |
| 03/27/2008 | US20080075773 Solid oral composition comprising 3-(5-methoxy-1H-indol-3-yl-methylene)-N-pentylcarbazimidamide or salt and disintegrant comprising crospovidone, sodium starch glycolate, carboxymethylcellulose sodium, sodium alginate; for administering active agents which are poorly soluble in water or acid sensitive |
| 03/27/2008 | US20080075762 Compositions for delivery of drug combinations |
| 03/27/2008 | US20080075728 Combination Therapies Of Hmgb And Complement Inhibitors Against Inflammation |
| 03/27/2008 | US20080075727 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/27/2008 | US20080075693 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 03/27/2008 | DE102006042742A1 Nano-Vehikel für den transkutanen Transport, diese enthaltende Zubereitungen und deren Anwendung Nano vehicle for transcutaneous delivery, compositions containing them and their use |
| 03/27/2008 | CA2664247A1 Inhibitors of phosphodiesterase type-iv |
| 03/27/2008 | CA2664152A1 Serine hydrolase inhibitors |
| 03/27/2008 | CA2663737A1 Processes for the preparation of ciclesonide and its crystal form |
| 03/27/2008 | CA2662773A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/26/2008 | EP1903058A2 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 03/26/2008 | EP1903044A1 Adenosine Derivatives as A2A Receptor Agonists |
| 03/26/2008 | EP1902722A1 Agent for elevating adiponectin concentration |
| 03/26/2008 | EP1902046A1 Piperidine derivatives useful as histamine h3 antagonists |
| 03/26/2008 | EP1902045A1 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament |
| 03/26/2008 | EP1902032A1 Pharmaceutical compounds |
| 03/26/2008 | EP1901766A2 Use of fril proteins for reducing the production of pro-inflammatory cytokines |
| 03/26/2008 | EP1901765A1 Intralesional treatment of psoriasis |
| 03/26/2008 | EP1901759A1 Immunostimulatory method |
| 03/26/2008 | EP1901734A2 Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol |
| 03/26/2008 | EP1725567B1 Spirocyclic cyclohexane derivatives with affinity to the orl-1 receptor |
| 03/26/2008 | EP1660460B1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
| 03/26/2008 | EP1583763B1 Benzoazolylpiperazine derivatives having vr1-antagonist activity |
| 03/26/2008 | EP1573450A4 System and method for transparent early detection, warning, and intervention during a medical procedure |
| 03/26/2008 | EP1562934B1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 03/26/2008 | EP1455790B1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 03/26/2008 | EP1439179B1 New oripavine derivatives and their uses as medicines |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | CN101151033A Preventive and/or therapeutic agent for rheumatoid arthritis |
| 03/26/2008 | CN101151028A Topical gels compositions |
| 03/26/2008 | CN101148638A Marrow-strengthening cold-dispersing nourishing wine |
| 03/26/2008 | CN101148476A Inflammation related disease target treatment fusion protein |
| 03/26/2008 | CN101148437A Biinomenine derivative connected with C-C bond, preparation method and application thereof |
| 03/26/2008 | CN101147795A Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia |
| 03/26/2008 | CN101147788A Medicine for treating cold and upper respiratory tract infection and its lung inflammation |
| 03/26/2008 | CN101147772A Fuming and washing medicine for treating sheath tube stenosis |
| 03/26/2008 | CN101147756A Medicinal composition containing total alooerine and licorice total flavone |
| 03/26/2008 | CN101147735A Pharmaceutical composition for injection and its medicine box |
| 03/26/2008 | CN101147731A Tramadol hydrochloride and paracetamol combined injection |
| 03/26/2008 | CN100377465C Intelligent serial cell charger and charging circuit block |
| 03/26/2008 | CN100376679C Protease, gene therefor and use thereof |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/26/2008 | CN100376567C Qinazoline derivatives as VEGF inhibitors |
| 03/26/2008 | CN100376554C N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376270C Externally applied medicine ointment for treating Yin-icterus and bone Bi-syndrome and its preparation process |
| 03/26/2008 | CN100376260C Method for preparing Qingkailing preparation |
| 03/26/2008 | CN100376255C Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatary activity and anti-atherogenic activity |
| 03/26/2008 | CN100376245C Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 03/26/2008 | CN100376242C 2-aryl-propionic acid and medicine composition containing same |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348400 α-conotoxin peptides with analgesic properties |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |